U.S. markets close in 2 hours 2 minutes

KBRA Releases Research – Coronavirus (COVID-19): KBRA Monitoring ABS Aircraft Securitizations

Kroll Bond Rating Agency (KBRA) releases a research report discussing ABS aircraft securitizations owing to coronavirus concerns.

The global spread of the coronavirus disease (COVID-19) is leading to negative ramifications on worldwide air travel. While it is too early to determine the full scope of the contagion’s effect on daily life and business activity, KBRA’s Aviation ABS Group anticipates that continued increases in documented cases of the virus could have an adverse impact on the short-term demand for air travel. Further, this scenario could directly influence aviation ABS transactions by possibly reducing the amount of cash available for such transactions. KBRA is actively monitoring the situation including the potential ramifications on our aviation ABS portfolio, which encompasses 48 transactions outstanding with an initial issuance size of more than $26 billion from 2013 to 2020.

To view the report, click here.

Related Publications:


About KBRA and KBRA Europe

KBRA is a full-service credit rating agency registered with the U.S. Securities and Exchange Commission as an NRSRO. In addition, KBRA is designated as a designated rating organization by the Ontario Securities Commission for issuers of asset-backed securities to file a short form prospectus or shelf prospectus. KBRA is also recognized by the National Association of Insurance Commissioners as a Credit Rating Provider, and is a certified Credit Rating Agency (CRA) by the European Securities and Markets Authority (ESMA). Kroll Bond Rating Agency Europe Limited is registered with ESMA as a CRA.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200310005996/en/


Alan Greenblatt, Senior Director
+1 (646) 731-2496

Rosemary Kelley, Senior Managing Director
+1 (646) 731-2337

Cecil Smart, Jr., Managing Director
+1 (646) 731-2381

Business Development:
Ted Burbage, Managing Director
+1 (646) 731-3325